EIF4E and neoplasm: In the Eu-myc mouse lymphoma model [16, 20, 21], expression of wild-type eIF4E, the phosphomimetic eIF4E-S209D mutant, or activation of the eIF4E kinase Mnk1 all accelerated tumor development.